Prosecution Insights
Prosecution Insights
Tech Center 1600 • Art Units: 1637 1681 1682 1699
This examiner grants 55% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18620056 | METHODS FOR EARLY DETECTION OF CANCER | Non-Final OA | GUARDANT HEALTH, INC. |
| 19449295 | DETECTING MUTATIONS AND PLOIDY IN CHROMOSOMAL SEGMENTS | Non-Final OA | Natera, Inc. |
| 17260611 | POLYNUCLEOTIDE SYNTHESIS METHOD, KIT AND SYSTEM | Final Rejection | Oxford Nanopore Technologies PLC |
| 18499328 | DNA UNFOLDING USING A FREE-END TAG FLOW MODIFIER | Non-Final OA | Robert Bosch GmbH |
| 17625687 | LIPID-MODIFIED OLIGONUCLEOTIDES AND METHODS OF USING THE SAME | Non-Final OA | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA |
| 17531488 | CONTACTLESS DETECTION OF AN ABERRANT CONDITION | Non-Final OA | Singular Genomics Systems, Inc. |
| 17438038 | METHODS FOR USING SPATIAL ARRAYS FOR SINGLE CELL SEQUENCING | Non-Final OA | 10x Genomics, Inc. |
| 17118429 | NUCLEIC ACID AMPLIFICATION METHOD | Final Rejection | Keygene N.V. |
| 17373653 | cDNA SPIKE-IN CONTROL FOR SINGLE CELL ANALYSIS | Non-Final OA | Becton, Dickinson and Company |
| 17619154 | METHOD FOR DIAGNOSIS OF EARLY AGEING OF THE SKIN | Non-Final OA | L'OREAL |
| 18489441 | ASSAY FOR DETECTION OF SARS-COV-2 | Non-Final OA | Imam Abdulrahman Bin Faisal University |
| 18573770 | METHODS FOR PREPARING SIGNALS FOR CONCURRENT SEQUENCING | Non-Final OA | Illumina, Inc. |
| 18558057 | AMPLIFICATION TECHNIQUES FOR NUCLEIC ACID CHARACTERIZATION | Non-Final OA | ILLUMINA, INC. |
| 17928452 | USE OF MICROVESICLE SIGNATURE FOR THE DIAGNOSIS AND TREATMENT OF KIDNEY TRANSPLANT REJECTION | Non-Final OA | The Brigham and Women's Hospital, Inc. |
| 17651135 | SINGLE TUBE PREPARATION OF DNA AND RNA FOR SEQUENCING | Non-Final OA | Roche Sequencing Solutions, Inc. |
| 17240865 | EXPONENTIAL BASE-3 AND GREATER NUCLEIC ACID AMPLIFICATION WITH CYCLING PROBE | Non-Final OA | Cepheid |
| 17602577 | COMPOSITIONS AND METHODS FOR NUCLEOTIDE MODIFICATION-BASED DEPLETION | Non-Final OA | ARC BIO, LLC |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy